FINWIRES · TerminalLIVE
FINWIRES

午盤漲幅最大的股票

By

-- Cue Biopharma (CUE) 股價在宣布與部分投資者簽署約 3000 萬美元的私募股權融資協議 (PIPE) 並任命林紹利 (Shao-Lee Lin) 為總裁兼首席執行官後,當日飆升 144%。 該公司當日成交量超過 1,630 萬股,而每日平均成交量約為 35.6 萬股。 Hemab Therapeutics (COAG) 週四宣布,其首次公開募股 (IPO) 定價為每股 18 美元,發行 1,680 萬股,總募資額為 3.015 億美元。 該股於週五在納斯達克全球精選市場開始交易,當日漲幅達 66%,成交量為 187 萬股。 摩根士丹利週五發布的一份報告稱,Twilio (TWLO) 第一季度業績超出預期,人工智慧驅動的應用案例成長勢頭強勁,業務表現也強於預期。 股價飆漲 20%,盤中交易量超過 444 萬股,日均交易量約為 244 萬股。

Price: $34.70, Change: $+19.96, Percent Change: +135.41%

Related Articles

Research

Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.

$BIO
Insider Trading

Comfort Systems USA Insider Sold Shares Worth $889,890, According to a Recent SEC Filing

Pablo G. Mercado, Director, on April 30, 2026, sold 500 shares in Comfort Systems USA (FIX) for $889,890. Following the Form 4 filing with the SEC, Mercado has control over a total of 3,000 common shares of the company, with 3,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035983/000153524626000004/xslF345X05/form4-05012026_040501.xml

$FIX
Insider Trading

Kaiser Aluminum Insider Sold Shares Worth $524,757, According to a Recent SEC Filing

Keith Harvey, Director, President & CEO, on April 29, 2026, sold 3,031 shares in Kaiser Aluminum (KALU) for $524,757. Following the Form 4 filing with the SEC, Harvey has control over a total of 94,308 common shares of the company, with 94,308 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/811596/000119312526201545/xslF345X05/ownership.xml

$KALU